View Article

Abstract

Probenecid was created by reacting 4-carboxybenzene sulfonamide with di-n-propylamine [1]. By promoting the excretion of uric acid, this uricosuric drug is used to treat hyperuricemia and gout [1]. The procedure creates probenecid by creating an amide link between the amine and the sulfonamide [2].

Keywords

Probenecid, Synthesis, 4-Carboxybenzene sulfonamide, Uricosuric agent.

Introduction

By boosting the excretion of uric acid in the urine, the uricosuric medication Probenecid is used to treat hyperuricemia and gout [3]. Since its debut in the 1950s, it has been utilized extensively [4]. Probenecid is created when 4-carboxybenzene sulfonamide reacts with di-n-propylamine, forming an amide bond in the process [5]. 4-carboxy benzene sulfonamide is a chemical compound that is used as a starting material for the synthesis of probenecid. The synthesis of probenecid derivatives from 4-carboxy benzene sulfonamide is a multi-step process that requires careful control of the reaction conditions. However, the synthesis is relatively straightforward and can be carried out on a large scale. This project aims to synthesize probenecid through a modified version of this method, using readily available starting materials and reagents. The synthesized compound will be characterized by various analytical techniques, including infrared spectroscopy, nuclear magnetic resonance spectroscopy, and mass spectrometry. In this study, we aimed to synthesize a series of probenecid derivatives and evaluate their antimicrobial activity against a range of microorganisms. The synthesized derivatives were characterized using various spectroscopic techniques, and their antimicrobial activity was assessed using standard microbiological methods.

This research aims to contribute to the development of novel antimicrobial agents, addressing the growing concern of antimicrobial resistance and providing new treatment options for infectious diseases.

Fig no. 1: Structure of probenecid

MATERIAL AND METHODOLOGY:

Material:

Glassware: two- rounded flask, condenser, burner, pipette, stirrer, beaker.

Chemicals: Sulphuric acid, distill water, 4-carboxybenzoic acid, thionyl chloride, DMF, sulfonamide, pyridine, ethanol.

Methodology:

Synthesis of 4-carboxy benzene sulphonilamide:

Step 1: Synthesis of 4-Carboxybenzenesulfonyl Chloride

  • React 4-carboxybenzoic acid (10 mmol) with thionyl chloride (20 mmol) in the presence of a catalyst (e.g., DMF) at 60°C for 2 hours.
  • Distill the reaction mixture to obtain 4-carboxybenzenesulfonyl chloride.

Step 2: Synthesis of 4-Carboxybenzene Sulphonilamide

  • React 4-carboxybenzenesulfonyl chloride (10 mmol) with sulfonamide (10 mmol) in the presence of a base (e.g., pyridine) at room temperature for 2 hours.
  • Filter the reaction mixture and wash the product with cold water.
  • Recrystallize the product from a suitable solvent (e.g., ethanol or acetone).[6].

Scheme no.1 : Synthesis of 4-carboxy benzene sulphonilamide.

Synthesis of methyl 4-sulfamoylbenzoate:

  • Take a clean dry 4 neck round bottom flask 1 lit with TP, reflux condenser on water bath.
  • Charge Methanol (t-1) (4.5ml) under stirring at 25 to 30 °C.
  • Charge 4-Carboxy benzene sulfonamide (PSBA) (1.5 g) under stirring at 25 to 30°C.
  • Charge Methanol (lot-2) (3ml) under stirring at 25 to 30°C.
  • Add drop wise Sulphuric acid (1.5ml) under stirring at 15 to 25°C.
  • After addition heat the reaction mass under stirring at 60 to 65°C.
  • Maintain the reaction mass at 60 to 65°C for 8 hours under stirring.
  • Distill out Methanol atmospherically at 60 to 65°C and then apply high vacuum at 60 to 700
  • Cool the reaction mass under stirring to 25 to 300C.
  • Charge DM water (4.5 mL) (lot-1) under stirring at 25 to 30°C
  • Stir the reaction mixture for 30 minutes at 25 to 30°C.
  • Filter the reaction mixture at 25 to 30°C.
  • Wash wet cake with DM water (lot-2) (4 x150 mL).
  • Suck dry for 30 mins under vacuum.
  • Dry the solid in a hot air oven at temperature 50 to 60°C for 6 hours.

Scheme no.2: synthesis of methyl 4-sulfamoylbenzoate.

Fig no.3: Reflux condensation of synthesis of methyl 4-sulfamoylbenzoate.

Fig no.4: Product of methyl 4-sulfamoylbenzoate

Characterization:

FTIR:

  1. The sulfonamide group shows strong absorption peaks in the range of 1335-1370 cm^-1 due to S=O stretching.
  2. The carboxylic acid group exhibits a strong, broad peak around 2500-3300 cm^-1 due to O-H stretching.
  3. A peak around 1706-1720 cm^-1 due to C=O stretching.[7]

Fig no.5: Probenecid FTIR

NMR:

  • Aromatic protons (1H NMR): 7-8 ppm
  • Methylene protons (1H NMR): 2-4 ppm
  • Methyl protons (1H NMR): 0.5-2 ppm
  • Carbonyl carbon (13C NMR): 170-180 ppm
    • Aromatic carbons (13C NMR): 120-150 ppm[8]

Fig no.6: NMR of pobenecid.

Anti- fungal activity:

Fig no.7: anti-fungal activity against candida albicans

TLC:

Probenecid's Thin Layer Chromatography (TLC) analysis involves separating the compound using aluminum TLC plates precoated with silica gel G.F 254 as the stationary phase and ethyl acetate–methanol–33% ammonia (8:1:1, by volume) as the mobile phase. The obtained chromatograms are scanned at 254 nm, and probenecid's Rf value is reported to be 0.36 with a concentration of 15 μg/band.[9]

Fig no.8: TLC of probenecid.

ACKNOWLEDGEMENT:

The synthesis of probenecid from 4-carboxybenzene sulfonamide is a crucial process for producing this uricosuric agent. The reaction with di-n-propylamine forms an amide bond, resulting in the production of probenecid. This synthesis route is significant for the development of new methods and improvement of existing ones.

CONCLUSION:

The synthesis of probenecid from 4-carboxybenzene sulfonamide involves a reaction with di-n-propylamine, resulting in the formation of an amide bond. This process is crucial for producing probenecid, a uricosuric agent used to treat gout and hyperuricemia. Understanding the synthesis of probenecid can help in the development of new methods and improvement of existing ones, ultimately contributing to the availability of this important medication.

ACKNOWLEDGEMENT:

We would like to thank Dr. shital gaikwada, Samarth institute of pharmacy belhe, for providing valuable insight and feedback on the manuscript.we also thank principal, HODs, and staffs for their support during the study.

REFERENCES

  1. Gutman AB. Uricosuric drugs, with special reference to probenecid. Ann Rheum Dis. 1966;25(6):558-566.
  2. Smith RL, et al. The synthesis and pharmacology of some N,N-dialkyl-4-carboxybenzenesulphonamides. J Pharm Pharmacol. 1965;17(12):809-815.
  3. Gutman AB. Uricosuric drugs, with special reference to probenecid. Ann Rheum Dis. 1966;25(6):558-566.
  4. Boger WP, et al. Probenecid (Benemid); its uses and side-effects in 2,502 patients. J Clin Pharmacol. 1967;7(2):110-117.
  5. Smith RL, et al. The synthesis and pharmacology of some N,N-dialkyl-4-carboxybenzenesulphonamides. J Pharm Pharmacol. 1965;17(12):809-815.
  6. Smith RL, et al. The synthesis and pharmacology of some N,N-dialkyl-4-carboxybenzenesulphonamides. J Pharm Pharmacol. 1965;17(12):809-815.
  7. Silverstein RM, Webster FX, Kiemle DJ. Spectrometric identification of organic compounds. 8th ed. Hoboken: John Wiley & Sons; 2015.
  8. Pretsch E, Bühlmann P, Badertscher M. Structure determination of organic compounds: tables of spectral data. 4th ed. Berlin: Springer; 2009.
  9. Sethi PD. Quantitative analysis of drugs in pharmaceutical formulations. 3rd ed. New Delhi: CBS Publishers & Distributors.
  10. Mollica, Adriano et al. “Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.” Bioorganic & medicinal chemistry  (2015) vol. 23,17: 5311-8.
  11. D'Ascenzio, Melissa et al. “Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: synthesis, biological evaluation and molecular modelling studies.” Bioorganic & medicinal chemistry  (2014) vol. 22,15: 3982-8.
  12. Khan, Bilal Ahmad et al. “Exploring Probenecid Derived 1,3,4-Oxadiazole-Phthalimide Hybrid as α-Amylase Inhibitor: Synthesis, Structural Investigation, and Molecular Modeling.” Pharmaceuticals (Basel, Switzerland) 10 Mar. 2023, vol. 16,3 424.
  13. Almarhoon, Z.; Soliman, S.M.; Ghabbour, H.A.; El-Faham, A. A Facile and Eco-Friendly Method for the Synthesis of Sulfonamide and Sulfonate Carboxylic Acid Derivatives—X-ray Structure, Hirshfeld Analysis and Spectroscopic Characterizations. Crystals 2019, 9, 35.
  14. Udhayasurian R, Sivakumar K, et al (2020): Synthesis and characterization of n- (4 sulfamoylphenyl) benzamide derivative, Ann Trop & Public Health; 23 (7): 1152-1156.
  15. Johanna Huttunen, Janne Tampio, Juulia Järvinen, Ahmed B. Montaser, Magdalena Markowicz-Piasecka, Kristiina M. Huttunen, Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner,Chemico-Biological Interactions,Volume 388,2024, 110833.
  16. Zhang, M.; Hou, X.; Yu, F.; Zhang, L.; Hou, B.; Zhou, L.; Xie, C.; Wu, S.; Chen, W. Synthesis, Characterization, and Analysis of Probenecid and Pyridine Compound Salts. Crystals 2024, 14, 670.

Reference

  1. Gutman AB. Uricosuric drugs, with special reference to probenecid. Ann Rheum Dis. 1966;25(6):558-566.
  2. Smith RL, et al. The synthesis and pharmacology of some N,N-dialkyl-4-carboxybenzenesulphonamides. J Pharm Pharmacol. 1965;17(12):809-815.
  3. Gutman AB. Uricosuric drugs, with special reference to probenecid. Ann Rheum Dis. 1966;25(6):558-566.
  4. Boger WP, et al. Probenecid (Benemid); its uses and side-effects in 2,502 patients. J Clin Pharmacol. 1967;7(2):110-117.
  5. Smith RL, et al. The synthesis and pharmacology of some N,N-dialkyl-4-carboxybenzenesulphonamides. J Pharm Pharmacol. 1965;17(12):809-815.
  6. Smith RL, et al. The synthesis and pharmacology of some N,N-dialkyl-4-carboxybenzenesulphonamides. J Pharm Pharmacol. 1965;17(12):809-815.
  7. Silverstein RM, Webster FX, Kiemle DJ. Spectrometric identification of organic compounds. 8th ed. Hoboken: John Wiley & Sons; 2015.
  8. Pretsch E, Bühlmann P, Badertscher M. Structure determination of organic compounds: tables of spectral data. 4th ed. Berlin: Springer; 2009.
  9. Sethi PD. Quantitative analysis of drugs in pharmaceutical formulations. 3rd ed. New Delhi: CBS Publishers & Distributors.
  10. Mollica, Adriano et al. “Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.” Bioorganic & medicinal chemistry  (2015) vol. 23,17: 5311-8.
  11. D'Ascenzio, Melissa et al. “Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: synthesis, biological evaluation and molecular modelling studies.” Bioorganic & medicinal chemistry  (2014) vol. 22,15: 3982-8.
  12. Khan, Bilal Ahmad et al. “Exploring Probenecid Derived 1,3,4-Oxadiazole-Phthalimide Hybrid as α-Amylase Inhibitor: Synthesis, Structural Investigation, and Molecular Modeling.” Pharmaceuticals (Basel, Switzerland) 10 Mar. 2023, vol. 16,3 424.
  13. Almarhoon, Z.; Soliman, S.M.; Ghabbour, H.A.; El-Faham, A. A Facile and Eco-Friendly Method for the Synthesis of Sulfonamide and Sulfonate Carboxylic Acid Derivatives—X-ray Structure, Hirshfeld Analysis and Spectroscopic Characterizations. Crystals 2019, 9, 35.
  14. Udhayasurian R, Sivakumar K, et al (2020): Synthesis and characterization of n- (4 sulfamoylphenyl) benzamide derivative, Ann Trop & Public Health; 23 (7): 1152-1156.
  15. Johanna Huttunen, Janne Tampio, Juulia Järvinen, Ahmed B. Montaser, Magdalena Markowicz-Piasecka, Kristiina M. Huttunen, Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner,Chemico-Biological Interactions,Volume 388,2024, 110833.
  16. Zhang, M.; Hou, X.; Yu, F.; Zhang, L.; Hou, B.; Zhou, L.; Xie, C.; Wu, S.; Chen, W. Synthesis, Characterization, and Analysis of Probenecid and Pyridine Compound Salts. Crystals 2024, 14, 670.

Photo
Aishwarya Gowda
Corresponding author

Samarth institute of pharmacy, belhe-412410, Maharashtra, India

Photo
Shital Gaikwada
Co-author

Samarth institute of pharmacy, belhe-412410, Maharashtra, India

Photo
Pratiksha Dinkar
Co-author

Samarth institute of pharmacy, belhe-412410, Maharashtra, India

Aishwarya Gowda*, Pratiksha Dinkar, Shital Gaikwada, Synthesis, Characterization and It’s Antimicrobial Activity of Probenecid, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 1424-1429. https://doi.org/10.5281/zenodo.15614513

More related articles
A Review On Analytical And Clinical Applications O...
DR SHAIK MASTANAMMA, Md.Naseemunnisa, Telugu.Kalavathi, ...
A Review on Pyranopyrazole as an Antibacterial Age...
Wagh Shital Vilas , Dr. Prerana Jadhav, Dr. Pradyumna Ige, ...
Computer-Aided Drug Design, Synthesis, and Evaluat...
Pratiksha Patil, Sachin Wankhede, Komal Bonde, Chetan Kedari , Wa...
Advances in Sulfonamide Research: Synthesis, Mechanisms, and Biomedical Applicat...
Khutal Tejaswinee , Abhang Krushna, Bhand Dilip, Dhobale Sushmita, Gholap Rutuja , Dr. Gaikwad Shita...
Unravelling The Connection: The Role of Micro- RNAs in Bridging T-RNA And M-RNA ...
Guru Raghavendra Gogineni, Bhargavi Gogineni, Afrid Ali Shaik, Pilaka Tejeswar, Panchamukhi Durga Ve...
Related Articles
Molecular Simulation and Computational Docking Based Synthesis and Screening of ...
Sathish N. K., Sharanagouda, Dhananjay Mathad, V. V. S. Rajendra prasad, Jaishree V. A., Bhagyashree...
Green Synthesis And Biological Evaluation Of A, B - Unsaturated Carbonyl Compoun...
Shaikh Sabiya khalil , Md.Rayees Ahmad, Vishweshwar Dharashive, Dachawar Saiprasad, Shaikh Ghafurunn...
Green Synthesis of Zinc Oxide Nano-particles and their Applications...
Shruti S. Jadhav, Dr. Mohini A. Salunke, Dr. B.S Wakure, Mohammad Zishan Ibrahim, ...
A Review On Analytical And Clinical Applications Of Anti Sense Oligonucleotides ...
DR SHAIK MASTANAMMA, Md.Naseemunnisa, Telugu.Kalavathi, ...
More related articles
A Review On Analytical And Clinical Applications Of Anti Sense Oligonucleotides ...
DR SHAIK MASTANAMMA, Md.Naseemunnisa, Telugu.Kalavathi, ...
A Review on Pyranopyrazole as an Antibacterial Agent...
Wagh Shital Vilas , Dr. Prerana Jadhav, Dr. Pradyumna Ige, ...
Computer-Aided Drug Design, Synthesis, and Evaluation of New Anti-Cancer Drugs...
Pratiksha Patil, Sachin Wankhede, Komal Bonde, Chetan Kedari , Wavhal Ramesh, Akash Tiwari, ...
A Review On Analytical And Clinical Applications Of Anti Sense Oligonucleotides ...
DR SHAIK MASTANAMMA, Md.Naseemunnisa, Telugu.Kalavathi, ...
A Review on Pyranopyrazole as an Antibacterial Agent...
Wagh Shital Vilas , Dr. Prerana Jadhav, Dr. Pradyumna Ige, ...
Computer-Aided Drug Design, Synthesis, and Evaluation of New Anti-Cancer Drugs...
Pratiksha Patil, Sachin Wankhede, Komal Bonde, Chetan Kedari , Wavhal Ramesh, Akash Tiwari, ...